1-3 of 3
Mariana Ferraro
Close
Sort by
Journal Articles

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

Blanca Sanchez-Gonzalez, MD PhD, Montserrat Garcia-Retortillo, MD PhD, Teresa Murcia, PhD, Mariana Ferraro, MD, Francesc Garcia-Pallarols, BSc, Dolors Gimenez, Sara Montesdeoca, Eva Gimeno, MD PhD, Eugenia Abella, MD PhD, Ricard Sola, MD PhD, Carlos Besses, MD PhD, Antonio Salar, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1801.
https://doi.org/10.1182/blood.V128.22.1801.1801
Published: 2016
Journal Articles

Hypogammaglobulinaemia and Infectious Toxicity Related with the Use of Maintenance Strategies with Rituximab in B Lymphomas

Lucia García Mañó, MD, Leyre Bento, MD, Jordi Martinez-Serra, Antonio Salar, MD PhD, Jose Maria Sanchez Raga, Inés Herráez, MD, Silvia Ruiz-de Gracia, MD, Marta García-Recio, MD, Mariana Ferraro, Francesc Garcia, Juan Besalduch, Antonia Sampol, Antonio Gutierrez, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5100.
https://doi.org/10.1182/blood.V126.23.5100.5100
Published: 2015
Journal Articles

Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14

Leyre Bento, MD, Francesc Garcia, PhD, Antonia Maria Bautista-Gili, Blanca Sanchez, Lucia Garcia, MD, Eva Gimeno, Jordi Martinez-serra, PhD, Mariana Ferraro, Raquel Del campo, Javier Vercher, Miguel Scaff, Ana Pacheco, Florencia Garcia, Rafael Ramos, MD, Carmen Ballester, Juan Besalduch, MD PhD, Joan Bargay, MD, Antonio Salar, MD, Antonio Gutierrez, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3073.
https://doi.org/10.1182/blood.V124.21.3073.3073
Published: 2014